THE UNIVERSITY OF WESTERN AUSTRALIA
Patent Owner
Stats
- 44 US PATENTS IN FORCE
- 5 US APPLICATIONS PENDING
- Feb 22, 2018 most recent publication
Details
- 44 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 4,575 Total Citation Count
- Aug 04, 1980 Earliest Filing
- 50 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2018/0051,282 ANTISENSE OLIGONUCLEOTIDES FOR INDUCING EXON SKIPPING AND METHODS OF USE THEREOFMar 23, 17Feb 22, 18[C12N]
2017/0009,234 ANTISENSE OLIGONUCLEOTIDES FOR INDUCING EXON SKIPPING AND METHODS OF USE THEREOFSep 23, 16Jan 12, 17[C12N]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9885023 Cytochrome P450 and cytochrome P450 reductase polypeptides, encoding nucleic acid molecules and uses thereofOct 31, 13Feb 06, 18[C11B, C12P, C12N]
9605262 Antisense oligonucleotides for inducing exon skipping and methods of use thereofJun 15, 15Mar 28, 17[C07H, C12N]
9447415 Antisense oligonucleotides for inducing exon skipping and methods of use thereofSep 17, 15Sep 20, 16[C07H, C12N]
9441229 Antisense oligonucleotides for inducing exon skipping and methods of use thereofSep 11, 15Sep 13, 16[C07H, C12N]
9422555 Antisense oligonucleotides for inducing exon skipping and methods of use thereofSep 17, 15Aug 23, 16[C07H, C12N]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2017/0009,233 ANTISENSE OLIGONUCLEOTIDES FOR INDUCING EXON SKIPPING AND METHODS OF USE THEREOFAbandonedSep 23, 16Jan 12, 17[C12N]
2016/0002,635 ANTISENSE OLIGONUCLEOTIDES FOR INDUCING EXON SKIPPING AND METHODS OF USE THEREOFAbandonedSep 18, 15Jan 07, 16[C12N]
2015/0057,330 ANTISENSE OLIGONUCLEOTIDES FOR INDUCING EXON SKIPPING AND METHODS OF USE THEREOFAbandonedMar 24, 14Feb 26, 15[C12N]
2014/0243,515 ANTISENSE OLIGONUCLEOTIDES FOR INDUCING EXON SKIPPING AND METHODS OF USE THEREOFAbandonedMay 08, 14Aug 28, 14[C12N]
2014/0243,516 ANTISENSE OLIGONUCLEOTIDES FOR INDUCING EXON SKIPPING AND METHODS OF USE THEREOFAbandonedMay 08, 14Aug 28, 14[C12N]
2014/0155,587 ANTISENSE OLIGONUCLEOTIDES FOR INDUCING EXON SKIPPING AND METHODS OF USE THEREOFAbandonedFeb 11, 14Jun 05, 14[C12N]
2014/0080,898 ANTISENSE OLIGONUCLEOTIDES FOR INDUCING EXON SKIPPING AND METHODS OF USE THEREOFAbandonedNov 21, 13Mar 20, 14[C12N]
2013/0331,438 ANTISENSE OLIGONUCLEOTIDES FOR INDUCING EXON SKIPPING AND METHODS OF USE THEREOFAbandonedAug 09, 13Dec 12, 13[C12N]
2013/0253,033 ANTISENSE OLIGONUCLEOTIDES FOR INDUCING EXON SKIPPING AND METHODS OF USE THEREOFAbandonedJan 14, 13Sep 26, 13[C12N]
2013/0253,180 ANTISENSE OLIGONUCLEOTIDES FOR INDUCING EXON SKIPPING AND METHODS OF USE THEREOFAbandonedMay 24, 13Sep 26, 13[C12N]
2013/0217,755 ANTISENSE OLIGONUCLEOTIDES FOR INDUCING EXON SKIPPING AND METHODS OF USE THEREOFAbandonedMar 14, 13Aug 22, 13[C12N]
2013/0205,455 SYSTEM AND METHOD OF PERFORMING ATOMIC FORCE MEASUREMENTSAbandonedFeb 07, 13Aug 08, 13[G01Q]
2013/0177,544 BIOMARKERS ASSOCIATED WITH PRE-DIABETES, DIABETES AND DIABETES RELATED CONDITIONSAbandonedSep 20, 11Jul 11, 13[G01N]
2013/0116,310 ANTISENSE OLIGONUCLEOTIDES FOR INDUCING EXON SKIPPING AND METHODS OF USE THEREOFAbandonedDec 26, 12May 09, 13[C12N]
2013/0090,366 MODULATION OF EPIDERMAL GROWTH FACTOR RECEPTOR LIGANDSAbandonedNov 24, 10Apr 11, 13[A61K, C12N]
8365923 Methods for selectively separating carbon nanotubesExpiredOct 30, 09Feb 05, 13[C01B, B03B, B82B]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.
